Overview
- The randomized feasibility trial reported in Nature Medicine on June 26, 2026, tested MultiSensy in 34 people more than three months after a stroke with twelve sessions delivered over three weeks.
- MultiSensy pairs immersive virtual‑reality tasks with transcutaneous electrical nerve stimulation so users feel virtual objects through skin electrodes while practicing reaching, grasping and hand tasks.
- Participants using MultiSensy showed nearly twice the improvement on the Fugl‑Meyer upper‑limb motor score versus conventional rehabilitation and also improved on the Action Research Arm Test and measures of touch and body perception.
- The platform adapts task difficulty to each person and records movement data to give objective, per‑session indicators clinicians can use to track and tailor therapy.
- Researchers caution the result is early evidence because the study was small and short; next steps include larger, longer trials to test durability, safety for home use, regulatory pathways and real‑world implementation.